Malaria Journal


Publication Venue For

  • Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.  19. 2020
  • Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes.  18. 2019
  • Metabolism of primaquine in normal human volunteers: Investigation of phase i and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry.  17. 2018
  • The malaria testing and treatment landscape in Kenya: Results from a nationally representative survey among the public and private sector in 2016.  16. 2017
  • When it just won't go away: Oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress.  16. 2017
  • Do anti-malarials in Africa meet quality standards? the market penetration of non quality-assured artemisinin combination therapy in eight African countries.  16. 2017
  • Private sector role, readiness and performance for malaria case management in Uganda, 2015..  16:219. 2017
  • Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015..  16:205. 2017
  • Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand..  16:180. 2017
  • The malaria testing and treatment landscape in Benin..  16:174. 2017
  • Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies..  16:171. 2017
  • Insights into the availability and distribution of oral artemisinin monotherapy in Myanmar: evidence from a nationally representative outlet survey..  16:170. 2017
  • What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism..  16:173. 2017
  • The malaria testing and treatment landscape in mainland Tanzania, 2016..  16:202. 2017
  • Predictors of the use of interventions to prevent malaria in pregnancy in Cameroon.  16. 2017
  • Pathway-specific inhibition of primaquine metabolism by chloroquine/quinine.  15. 2016
  • Differential kinetic profiles and metabolism of primaquine enantiomers by human hepatocytes.  15. 2016
  • Population-based prevalence of malaria among pregnant women in Enugu State, Nigeria: The Healthy Beginning Initiative.  14. 2015
  • Spatial patterns of incident malaria cases and their household contacts in a single clinic catchment area of Chongwe District, Zambia.  14. 2015
  • Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy?.  14. 2015
  • Communicating the AMFm message: Exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy intervention.  13. 2014
  • Enantioselective metabolism of primaquine by human CYP2D6.  13. 2014
  • Limited variation in vaccine candidate Plasmodium falciparum Merozoite Surface Protein-6 over multiple transmission seasons..  9:138. 2010
  • Electronic International Standard Serial Number (eissn)

  • 1475-2875